Sai Parenterals IPO Allotment Status: Issue Subscribed 1.05x Across NSE-BSE; Here’s How to Check Status

Sai Parenterals IPO Allotment Status: Issue Subscribed 1.05x Across NSE-BSE; Here’s How to Check Status​

Mumbai, March 29 (Sunday) – Sai Parenterals Limited is set to finalize its IPO allotment on March 30, 2026, with investors now focusing on how to check their application status. The issue saw a modest overall subscription of 1.05 times across NSE and BSE, with demand driven primarily by institutional and high-value investors.

How to Check Sai Parenterals IPO Allotment​

Investors can check their allotment status through registrar and exchange platforms:

1. Through Bigshare Services (Registrar)​

Visit: https://www.bigshareonline.com/ipo_allotment.html
Select Sai Parenterals Limited from the dropdown.
Choose one of the identifiers:

• Application Number
• DPID/Client ID
• PAN

Enter the required details and captcha.
Click Submit to view your allotment status.

2. Through BSE​

Visit: https://www.bseindia.com/investors/appli_check.aspx
Select Equity under Issue Type.
Choose Sai Parenterals Limited from the dropdown.
Enter Application Number and PAN.
Click Search to view the status.

3. Through NSE​

Visit: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
Select “Equity & SME IPO bid details”.
Choose Sai Parenterals Limited from the Select Symbol dropdown.
Enter any one of the following:

• PAN Number, or
• Application Number

Complete the captcha verification.
Click Submit/Search to view your bid and allotment details.

Subscription Details (NSE-BSE Combined)​

The IPO saw weak retail participation at 0.12x, while QIBs (1.71x) and high-value NIIs (3.43x) supported overall subscription.

Price Band Demand Trend​

Demand remained broadly stable across the price band, indicating evenly distributed bidding.

IPO Timeline​

Demand Insights​

The IPO’s subscription profile reflects selective investor interest, with strong demand concentrated in the high-ticket NII segment, while smaller investors remained largely on the sidelines.

What’s Next​

Following allotment finalization, refunds and credit of shares are expected on April 1, with listing scheduled on both NSE and BSE on April 2, 2026.

About the Company​

Sai Parenterals Limited is a pharmaceutical formulations company engaged in branded generics and CDMO services. Its portfolio spans multiple therapeutic areas, supported by capabilities in sterile injectables manufacturing, diversified dosage formats, and integrated operations across Telangana and Andhra Pradesh, backed by in-house R&D and an established product development framework.